Gamida Cell

About:

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.

Website: http://www.gamida-cell.com

Twitter/X: GamidaCellTx

Top Investors: Israel Innovation Authority, Novartis, Teva Pharmaceuticals, Israel Biotech Fund, Amgen Ventures

Description:

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases. Its product includes NiCord, a cell therapy based on NAM-expanded cord blood developed to improve and extend the life-saving benefits of hematopoietic stem cell transplant. The company applies an expansion platform supporting the properties of NAM to allogeneic cell sources that include omidubicel, an investigational product with potential as a life-saving alternative for patients in need of bone marrow transplant.